COMP <GO>
CE vs BCPC // FORWARD P/E MULTIPLE
Celanese Corporation (NYSE) VS. Balchem Corporation (NASDAQ) • 15-METRIC TALLY: CE 3
— BCPC 9
▲ FORWARD P/E MULTIPLE LEADER: CE
LAST: $48.32 (-1.08%) • MKT CAP: $5.30B
forward-pe
29.0x
LAST: $170.40 (+2.47%) • MKT CAP: $5.41B
forward-pe
32.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CE VS. BCPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CE | BCPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | 35.70% | -15.20 | BCPC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.70% | 14.00% | -24.70 | BCPC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 25.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 15.14% | 4.00% | +11.14 | CE | /fcf-yield <GO> |
| Operating Margin | -8.20% | 20.20% | -28.40 | BCPC | /operating-margins <GO> |
| Net Profit Margin | -12.20% | 14.90% | -27.10 | BCPC | /net-margins <GO> |
| Revenue Growth (YoY) | -7.10% | 8.80% | -15.90 | BCPC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.25% | 0.52% | -0.27 | BCPC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 9.67 | -8.30 | BCPC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | BCPC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.7 | 50.4 | +7.27 | CE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.0x | 32.6x | -3.60 | CE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.30B | $5.41B | -$111.8M | BCPC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CE REV | BCPC REV | CE GROSS % | BCPC GROSS % | CE FCF | BCPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.54B | $1.04B | 20.5% | 35.7% | $803.0M | $216.6M |
| FY 2024 | $10.27B | $953.7M | 22.8% | 35.3% | $531.0M | $182.0M |
| FY 2023 | $10.93B | $922.4M | — | — | $1.41B | $183.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CE // BETA 1.16
BCPC // BETA —